News

During development in the womb, immune cells called macrophages go to the kidneys, and they remain there for life. Understanding the possible healing role for these macrophages after kidney damage may be crucial to helping treat patients who suffer acute kidney injury.

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate.

This new vaccine reduced the malaria-causing parasite’s release from the liver and into the blood of infected rhesus macaques by 75 to 80 percent at the Oregon National Primate Research Center at OHSU.

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

Children with a history of prior dengue virus infection had a significantly lower risk of being symptomatic when infected by Zika virus.

Research team finds that mesenchymal progenitors can be grown without use of animal-derived compounds, a requirement for therapeutic applications.

Changes in mosquito behavior and selection in the parasites mean new strategies are needed for any hopes of eradicating the disease following stalling of the positive trend in 2015.

One in 10 children and about one in six adults with private insurance received antibiotics they didn’t need at least once in 2016, a new Michigan Medicine study suggests.

Scientists have developed a biological system which lets cells form a desired shape by moulding their surrounding material - initially creating the world's first self-curving cornea.

Deleting a certain type of estrogen receptor in an area of the hypothalamus dramatically increased bone density and strength in female mice, opening up many therapeutic possibilities for improving women's health.